CapForce, Inc. (CFOR)
6.02
-0.88
(-12.75%)
USD |
OTCM |
Nov 05, 16:00
CapForce Total Liabilities (Quarterly) : 13.40M for June 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 13.40M |
| March 31, 2026 | 6.197M |
| December 31, 2025 | 6.198M |
| September 30, 2025 | 2.481M |
| June 30, 2025 | 2.578M |
| March 31, 2025 | 2.364M |
| December 31, 2024 | 2.482M |
| September 30, 2024 | 2.484M |
| June 30, 2024 | 14.54M |
| March 31, 2024 | 13.68M |
| December 31, 2023 | 13.44M |
| September 30, 2023 | 15.46M |
| June 30, 2023 | 15.58M |
| March 31, 2023 | 17.33M |
| December 31, 2022 | 18.24M |
| September 30, 2022 | 19.02M |
| June 30, 2022 | 21.45M |
| March 31, 2022 | 30.09M |
| December 31, 2021 | 30.45M |
| September 30, 2021 | 28.99M |
| June 30, 2021 | 28.83M |
| March 31, 2021 | 29.12M |
| December 31, 2020 | 28.56M |
| September 30, 2020 | 27.63M |
| June 30, 2020 | 27.56M |
| Date | Value |
|---|---|
| March 31, 2020 | 5.681M |
| December 31, 2019 | 6.128M |
| September 30, 2019 | 7.987M |
| June 30, 2019 | 7.105M |
| March 31, 2019 | 7.752M |
| December 31, 2018 | 5.642M |
| September 30, 2018 | 5.193M |
| June 30, 2018 | 5.728M |
| March 31, 2018 | 5.311M |
| December 31, 2017 | 5.219M |
| September 30, 2017 | 5.458M |
| June 30, 2017 | 7.129M |
| March 31, 2017 | 5.603M |
| December 31, 2016 | 5.817M |
| September 30, 2016 | 6.300M |
| June 30, 2016 | 5.906M |
| March 31, 2016 | 6.425M |
| December 31, 2015 | 6.272M |
| September 30, 2015 | 5.053M |
| June 30, 2015 | 2.969M |
| March 31, 2015 | 6.726M |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Phio Pharmaceuticals Corp. | 1.705M |
| Agenus, Inc. | 378.54M |
| Amgen, Inc. | 81.70B |
| Anika Therapeutics, Inc. | 46.19M |
| BioCryst Pharmaceuticals, Inc. | 988.45M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 87.68M |
| Shareholders Equity (Quarterly) | 74.28M |
| Debt to Equity Ratio | 0.0264 |
| Current Ratio | 4.273 |
| Net Debt Paydown Yield | 0.00% |